In uveal melanoma cells in particular, treatment with a MEK inhibitor results in a potent downregulation of both EGR1 and its transcriptional targets [75], while forced reduction in EGR1 expression was reported to attenuate growth and impart sensitivity to MEK inhibition [76]. Here, MAP2K7 is linked to uveal melanoma.